Many patients with DLBCL may not need radiation after clear PET scan

ORLANDO — Nearly 90% of patients with limited-stage diffuse large B-cell lymphoma maintained excellent outcomes after four cycles of R-CHOP with PET-directed therapy, according to study findings presented at ASH Annual Meeting and Exposition.Patients with non-bulky stage I/II untreated DLBCL received standard R-CHOP therapy and an interim PET scan on day 15-18 of cycle 3, according to the

Read the full article here

Related Articles